Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT00543556
Eligibility Criteria:
Inclusion Criteria:
* Type 2 Diabetes Mellitus patients between the ages of 21 and 75 inclusive
* Patient is willing to discontinue current therapy for the duration of the study
* Patient is not a heavy drinker
Exclusion Criteria:
* Patient has a history of Type 1 diabetes and/or ketoacidosis
* Patient has severe diabetic retinopathy, or nephropathy, or neuropath
* Patient has has anti-hyperglycemic therapy including insulin, or rosiglitazone and pioglitazone or 2 or more oral agents in combination within 8 weeks prior to visit 1
* Patient has a history of, allergy to, intolerance or hypersensitive to troglitazone, rosiglitazone, or pioglitazone including history of elevated liver function test, jaundice, or hepatotoxicity associated with these treatments
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
75 Years
Study:
NCT00543556
Study Brief:
Protocol Section:
NCT00543556